Research progress of"four early"measures of cardiovascular toxicity in cancer patients
10.3781/j.issn.1000-7431.2025.2404-0232
- VernacularTitle:心血管毒性"四早"措施在肿瘤患者中的研究进展
- Author:
Yanqiu SONG
1
;
Lijuan YANG
;
Weifeng LI
Author Information
1. 山东第一医科大学附属省立医院奥体院区神经外科,山东 济南 250014
- Publication Type:Journal Article
- Keywords:
Cardiovascular toxicity;
Anti-tumor therapy;
Early assessment;
Early identification;
Early diagnosis;
Early treatment
- From:
Tumor
2025;45(2):202-216
- CountryChina
- Language:Chinese
-
Abstract:
At present,the treatment level of cancer has made great progress.However,cancer therapy-related cardiovascular toxicity can adversely affect the prognosis of cancer patients.Studies have found that the high risk of cardiovascular toxicity has gradually become an important factor for non-tumor mortality.Therefore,there is a growing interest in oncologic cardiology.However,there is still a lack of consensus on the optimal strategies for the identification,diagnosis,and intervention of cancer therapy-related cardiovascular toxicity.This article proposes for the first time the concept of"four early"measures for cancer therapy-related cardiovascular toxicity,namely early assessment of risk factors,early identification of clinical manifestations,early diagnosis through modern medical methods,and personalized intervention in the early stage after diagnosis.Combined with relevant research at home and abroad,this article also discusses the shortcomings of research on cancer therapy-related cardiovascular toxicity and proposes future development directions,aiming to provide reference for the prevention and treatment of cardiovascular toxicity events in patients undergoing anti-tumor treatment.
